Protection against pneumococcal pneumonia in mice by monoclonal antibodies to pneumolysin

Infection and Immunity

Volumn 72, Issue 8, 2004, Pages 4534-4540

  Del Mar García Suárez, María ^a,c   Cima Cabal, María Dolores ^a   Flórez, Noelia ^a   García, Pilar ^a   Cernuda Cernuda, Rafael ^a   Astudillo, Aurora ^b   Vázquez, Fernando ^a   De Los Toyos, Juan R ^a   Méndez, F Javier ^a  

^a UNIVERSIDAD DE OVIEDO   (Spain)

^b HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^c Faculty de Medicina   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY PNEUMOLYSIN; MONOCLONAL ANTIBODY PNEUMOLYSIN 4; MONOCLONAL ANTIBODY PNEUMOLYSIN 5; MONOCLONAL ANTIBODY PNEUMOLYSIN 7; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTEREMIA; BACTERIAL COLONIZATION; BACTERIAL VIRULENCE; CONTROLLED STUDY; DRUG POTENTIATION; LETHALITY; LOBAR PNEUMONIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE; SURVIVAL; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODIES, MONOCLONAL; BACTEREMIA; BACTERIAL PROTEINS; BLOOD; DRUG SYNERGISM; HUMANS; IMMUNIZATION, PASSIVE; INJECTIONS, INTRAVENOUS; LUNG; MICE; NEUTRALIZATION TESTS; PNEUMOCOCCAL VACCINES; PNEUMONIA, PNEUMOCOCCAL; STREPTOCOCCUS PNEUMONIAE; STREPTOLYSINS;

EID: 3342955366     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.72.8.4534-4540.2004     Document Type: Article

References (41)

1. Aaberge, I. S., J. Eng, G. Lermark, and M. Lovik. 1995. Virulence of Streptococcus pneumoniae in mice: a standardized method for preparation and frozen storage of experimental bacterial inoculum. Microb. Pathog. 18:141-152.
2. Adamou, J. E., J. H. Heinrichs, A. L. Erwin, W. Walsh, T. Gayle, M. Dormitzer, R. Dagan, Y. A. Brewah, P. Barren, R. Lathigra, S. Langermann, S. Koenig, and S. Johnson. 2001. Identification and characterization of a novel family of pneumococcal proteins that are protective against sepsis. Infect. Immun. 69:949-958.
3. Alexander, J. E., R. A. Lock, C. C. Peeters, J. T. Poolman, P. W. Andrew, T. J. Mitchell, D. Hansman, and J. C. Paton. 1994. Immunization of mice with pneumolysin toxoid confers a significant degree of protection against at least nine serotypes of Streptococcus pneumoniae. Infect. Immun. 62:5683-5688.
4. Alexander, J. E., A. M. Berry, J. C. Paton, J. B. Rubins, P. W. Andrew, and T. J. Mitchell. 1998. Amino acid changes affecting the activity of pneumolysin alter the behaviour of pneumococci in pneumonia. Microb. Pathog. 24:167-174.
5. Arulanandam, B. P., J. M. Lynch, D. E. Briles, S. Hollingshead, and D. W. Metzger. 2001. Intranasal vaccination with pneumococcal surface protein A and interleukin-12 augments antibody-mediated opsonization and protective immunity against Streptococcus pneumoniae infection. Infect. Immun. 69: 6718-6724.
6. Bergeron, Y., N. Ouellet, A. M. Deslauriers, M. Simard, M. Oliver, and M. G. Bergeron. 1998. Cytokine kinetics and other host factors in response to pneumococcal pulmonary infection in mice. Infect. Immun. 66:912-922.
7. Berry, A. M., A. D. Ogunniyi, D. C. Miller, and J. C. Paton. 1999. Comparative virulence of Streptococcus pneumoniae strains with insertion-duplication, point, and deletion mutations in the pneumolysin gene. Infect. Immun. 67:981-985.
8. Berry, A. M., and J. C. Paton. 2000. Additive attenuation of virulence of Streptococcus pneumoniae by mutation of the genes encoding pneumolysin and other putative pneumococcal virulence proteins. Infect. Immun. 68:133-140.
9. Bosarge, J. R., J. M. Watt, D. O. McDaniel, E. Swiatlo, and L. S. McDaniel. 2001. Genetic immunization with the region encoding the α-helical domain of PspA elicits protective immunity against Streptococcuspneumoniae. Infect. Immun. 69:5456-5463.
10. 2 mediate brain cell apoptosis during meningitis. J. Clin. Investig. 109:19-27.
11. Briles, D. E., M. J. Crain, B. M. Gray, C. Forman, and J. Yother. 1992. Strong association between capsular type and virulence for mice among human isolates of Streptococcus pneumoniae. Infect. Immun. 60:111-116.
12. Brown, J. S., A. D. Ogunniyi, M. C. Woodrow, D. W. Holden, and J. C. Paton. 2001. Immunization with components of two iron uptake ABC transporters protects mice against systemic Streptococcus pneumoniae infection. Infect. Immun. 69:6702-6706.
13. Cima-Cabal, M. D., F. Vázquez, J. R. de los Toyos, and F. J. Méndez. 1999. Rapid and reliable identification of Streptococcus pneumoniae isolates by pneumolysin-mediated agglutination. J. Clin. Microbiol. 37:1964-1966.
14. Cima-Cabal, M. D. 1999. PhD thesis. University of Oviedo, Oviedo, Spain.
15. de los Toyos, J. R., F. J. Méndez, J. F. Aparicio, F. Vázquez, M. M. García-Suárez, A. Fleites, C. Hardisson, P. J. Morgan, P. W. Andrew, and T. J. Mitchell. 1996. Functional analysis of pneumolysin by use of monoclonal antibodies. Infect. Immun. 64:480-484.
16. Diamandis, E. P., S. Nadkarni, B. Bhaumik, A. Abdelrahman, D. N. Melegos, G. Borchert, M. H. Black, M. Alonso, A. Salas, J. R. de los Toyos, A. Sampedro, and C. Lopez-Otin. 1997. Immunofluorometric assay of pepsinogen C and preliminary clinical applications. Clin. Chem. 43:1365-1371.
17. Dougherty, R. H. 1974. Animal virus titration techniques, p. 169-223. In R. J. C. Harris (ed.), Techniques in experimental virology. Academic Press, Inc., New York, N.Y.
18. Feldman, C., R. Anderson, R. Cockeran, T. Mitchell, P. Cole, and R. Wilson. 2002. The effects of pneumolysin and hydrogen peroxide, alone and in combination, on human ciliated epithelium in vitro. Respir. Med. 98:580-585.
19. Houldsworth, S., P. W. Andrew, and T. J. Mitchell. 1994. Pneumolysin stimules production of tumor necrosis factor alpha and interleukin-1β by human mononuclear phagocytes. Infect. Immun. 62:1501-1503.
20. Jacobs, T., M. D. Cima-Cabal, A. Darji, F. J. Méndez, F. Vázquez, A. A. C. Jacobs, Y. Shimada, Y. Ohno-Iwashita, S. Weiss, and J. R. de los Toyos. 1999. The conserved undecapeptide shared by thiol-activated cytolysins is involved in membrane binding. FEBS Lett. 459:463-466.
21. Johnson, S. E., L. Rubin, S. Romero-Steiner, J. K. Dykes, L. B. Pais, A. Rizvi, E. Ades, and G. M. Carlone. 1999. Correlation of opsonophagocytosis and passive protection assays using human anticapsular antibodies in an infant mouse model of bacteremia of Streptococcus pneumoniae. J. Infect. Dis. 180:133-140.
22. Kadioglu, A., N. A. Gingles, K. Grattan, A. Kerr, T. J. Mitchell, and P. W. Andrew. 2000. Host cellular immune response to pneumococcal lung infection in mice. Infect. Immun. 68:492-501.
23. Kadioglu, A., S. Taylor, F. Iannelli, G. Pozzi, T. J. Mitchell, and P. W. Andrew. 2002. Upper and lower respiratory tract infection by Streptococcus pneumoniae is affected by pneumolysin deficiency and differences in capsule type. Infect. Immun. 70:2886-2890.
24. Lock, R. A., D. Hansman, and J. C. Paton. 1992. Comparative efficacy of autolysin and pneumolysin as immunogens protecting mice against infection Streptococcus pneumoniae. Microb. Pathog. 12:137-143.
25. McDaniel, L. S., G. Scott, J. F. Kearney, and D. E. Briles. 1984. Monoclonal antibodies against protease-sensitive pneumococcal antigens can protect mice from fatal infection with Streptococcus pneumoniae. J. Exp. Med. 160: 386-397.
26. Mitchell, T. J., F. Méndez, J. C. Paton, P. W. Andrew, and G. J. Boulnois. 1990. Comparison of pneumolysin genes and proteins from Streptococcus pneumoniae types 1 and 2. Nucleic Acids Res. 18:4010.
27. Musher, D. M. 1999. Streptococcus pneumoniae, p. 2129-2156. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Principles and practice of infectious diseases, 5th ed., vol. 2. Churchill Livingstone, New York, N.Y.
28. Musher, D. M., H. M. Phan, and R. Baughn. 2001. Protection against bacteremic pneumococcal infection by antibody to pneumolysin. J. Infect. Dis. 183:827-830.
29. Ogunniyi, A. D., R. L. Folland, D. E. Briles, S. K. Hollingshead, and J. C. Paton. 2000. Immunization of mice with combinations of pneumococcal virulence proteins elicits enhanced protection against challenge with Streptococcus pneumoniae. Infect. Immun. 68:3028-3033.
30. Ogunniyi, A. D., M. C. Woodrow, J. T. Poolman, and J. C. Paton. 2001. Protection against Streptococcus pneumoniae elicited by immunization with pneumolysin and CbpA. Infect. Immun. 69:5997-6003.
31. Palmer, M. 2001. The family of thiol-activated, cholesterol-binding cytolysins. Toxicon 39:1681-1689.
32. Paton, J. C., and A. Ferrante. 1983. Inhibition of human polymorphonuclear leukocyte respiratory burst, bactericidal activity, and migration by pneumolysin. Infect. Immun. 41:1212-1216.
33. Paton, J. C., B. Rowan-Kelly, and A. Ferrante. 1984. Activation of human complement by the pneumococcal toxin pneumolysin. Infect. Immun. 43: 1085-1087.
34. Reed, L. J., and H. Muench. 1938. A simple method of estimating fifty per cent endpoints. Am. J. Hyg. 27:493-497.
35. Rosenow, C., P. Ryan, J. N. Weiser, S. Johnson, P. Fontan, A. Ortqvist, and H. R. Masure. 1997. Contribution of novel choline-binding proteins to adherence, colonization and immunogenicity of Streptococcus pneumoniae. Mol. Microbiol. 25:819-829.
36. Saeland, E., G. Vidarsson, and I. Jonsdottir. 2000. Pneumococcal pneumonia and bacteremia model in mice for the analysis of protective antibodies. Microb. Pathog. 29:81-91.
37. Saeland, E., H. Jakobsen, G. Ingolfsdottir, S. T. Sigurdardottir, and I. Jonsdottir. 2001. Serum samples from infants vaccinated with a pneumococcal conjugate vaccine, PncT, protect mice against invasive infection caused by Streptococcus pneumoniae serotypes 6A and 6B. J. Infect. Dis. 183:253-260.
38. Suárez-Álvarez, B., M. M. García-Suárez, F. J. Méndez, and J. R. de los Toyos. 2003. Characterisation of mouse monoclonal antibodies for pneumolysin: fine epitope mapping and V gene usage. Immunol. Lett. 88:227-239.
39. Swiatlo, E., and D. Ware. 2003. Novel vaccine strategies with protein antigens of Streptococcus pneumoniae. FEMS Immunol. Med. Microbiol. 38:1-7.
40. Wizemann, T., J. H. Heinrichs, J. E. Adamou, A. L. Erwin, C. Kunsch, G. H. Choi, S. C. Barash, C. A. Rosen, H. R. Masure, E. Tuomanen, A. Gayle, Y. A. Brewah, W. Walsh, P. Barren, R. Lathigra, M. Hanson, S. Langermann, S. Johnson, and S. Koenig. 2001. Use of a whole-genome approach to identify vaccine molecules affording protection against Streptococcus pneumoniae infection. Infect. Immun. 69:1593-1598.
41. Wuorimaa, T., and H. Käyhty. 2002. Current state of pneumococcal vaccines. Scand. J. Immunol. 56:111-129.